Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1281342rdf:typepubmed:Citationlld:pubmed
pubmed-article:1281342lifeskim:mentionsumls-concept:C0521324lld:lifeskim
pubmed-article:1281342lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:1281342lifeskim:mentionsumls-concept:C0030231lld:lifeskim
pubmed-article:1281342lifeskim:mentionsumls-concept:C0206113lld:lifeskim
pubmed-article:1281342lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:1281342lifeskim:mentionsumls-concept:C0205391lld:lifeskim
pubmed-article:1281342pubmed:issue27lld:pubmed
pubmed-article:1281342pubmed:dateCreated1993-1-13lld:pubmed
pubmed-article:1281342pubmed:abstractTextIn a large number of cancer patients, extensive skeletal metastases or myelomatosis induce vast suffering, such as intolerable pain and local complications of neoplastic bone destruction. Analgetic drugs frequently do not yield sufficient palliation. Irradiation of local fields often has to be repeated, because of tumour growth outside previously irradiated volumes. Wide field irradiation of the lower or upper half of the body causes significant relief of pain in most patients. Adequate pretreatment handling of patients, method of irradiation, and follow-up are of marked importance to reduce side effects, and are described as they are carried out at the Department of Oncology, Haukeland Hospital.lld:pubmed
pubmed-article:1281342pubmed:languagenorlld:pubmed
pubmed-article:1281342pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1281342pubmed:citationSubsetIMlld:pubmed
pubmed-article:1281342pubmed:statusMEDLINElld:pubmed
pubmed-article:1281342pubmed:monthNovlld:pubmed
pubmed-article:1281342pubmed:issn0029-2001lld:pubmed
pubmed-article:1281342pubmed:authorpubmed-author:DahlOOlld:pubmed
pubmed-article:1281342pubmed:authorpubmed-author:MellaOOlld:pubmed
pubmed-article:1281342pubmed:authorpubmed-author:SchemB CBClld:pubmed
pubmed-article:1281342pubmed:issnTypePrintlld:pubmed
pubmed-article:1281342pubmed:day10lld:pubmed
pubmed-article:1281342pubmed:volume112lld:pubmed
pubmed-article:1281342pubmed:ownerNLMlld:pubmed
pubmed-article:1281342pubmed:authorsCompleteYlld:pubmed
pubmed-article:1281342pubmed:pagination3446-9lld:pubmed
pubmed-article:1281342pubmed:dateRevised2008-7-16lld:pubmed
pubmed-article:1281342pubmed:meshHeadingpubmed-meshheading:1281342-...lld:pubmed
pubmed-article:1281342pubmed:meshHeadingpubmed-meshheading:1281342-...lld:pubmed
pubmed-article:1281342pubmed:meshHeadingpubmed-meshheading:1281342-...lld:pubmed
pubmed-article:1281342pubmed:meshHeadingpubmed-meshheading:1281342-...lld:pubmed
pubmed-article:1281342pubmed:meshHeadingpubmed-meshheading:1281342-...lld:pubmed
pubmed-article:1281342pubmed:year1992lld:pubmed
pubmed-article:1281342pubmed:articleTitle[Half-body irradiation. An effective palliative treatment of widespread skeletal metastases].lld:pubmed
pubmed-article:1281342pubmed:affiliationOnkologisk avdeling, Haukeland sykehus, Bergen.lld:pubmed
pubmed-article:1281342pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1281342pubmed:publicationTypeEnglish Abstractlld:pubmed